Published in Oncol Lett on July 24, 2012
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol (2008) 6.43
Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg (1998) 5.87
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol (1998) 5.74
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet (1997) 4.45
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol (2010) 4.01
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol (2002) 3.49
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol (2001) 3.29
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol (2009) 2.89
A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J (2005) 2.71
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med (2008) 2.70
Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies. J Clin Oncol (2008) 2.65
Inferior vena cava leiomyosarcoma: is reconstruction necessary after resection? J Am Coll Surg (2010) 2.08
Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer (1996) 2.06
Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol (1985) 1.87
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg (1996) 1.35
Activity of Sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res (2011) 1.31
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies. Clin Cancer Res (2009) 1.30
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Ann Oncol (2011) 1.29
Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer (1992) 1.28
Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther (2010) 1.27
The changing role of amputation for soft tissue sarcoma of the extremity in adults. Surg Gynecol Obstet (1992) 1.20
Translating gene expression into clinical care: sarcomas as a paradigm. J Clin Oncol (2010) 1.18
Irinotecan for children with relapsed solid tumors. Pediatr Hematol Oncol (2006) 1.17
Sirolimus treatment for pulmonary lymphangioleiomyomatosis. Ann Intern Med (2007) 1.14
Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma. Semin Surg Oncol (1988) 1.12
Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys (1998) 1.07
Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients. Cancer (1985) 1.05
Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol (2009) 1.05
Surgical therapy of lung metastases. Semin Oncol (2007) 1.01
Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg (1991) 0.98
Soft tissue sarcoma of the upper extremity: a 5-year experience at two institutions emphasizing the role of soft tissue flap reconstruction. Cancer (2002) 0.98
Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway. Cancer Biol Ther (2009) 0.98
Epithelioid soft tissue tumors. Semin Oncol (2009) 0.96
Surgical treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin North Am (1995) 0.94
Molecular characterization of interdigitating dendritic cell sarcoma. Rare Tumors (2010) 0.92
Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol (2011) 0.92
Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type? Semin Oncol (2011) 0.91
Desmoid tumor treated with polychemotherapy followed by imatinib: a case report and review of the literature. Case Rep Oncol (2010) 0.90
Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy. Cancer (1993) 0.88
Metastasectomy for limited metastases from soft tissue sarcoma. Curr Treat Options Oncol (2002) 0.88
Sarcoma in the young adult population: an international view. Semin Oncol (2009) 0.87
A new approach to the resection of pulmonary osteosarcoma metastases. Results of aggressive metastasectomy. Clin Orthop Relat Res (1991) 0.87
The many faces of chondrosarcoma of bone, own cases and review of the literature with an emphasis on radiology, pathology and treatment. Acta Chir Orthop Traumatol Cech (2011) 0.86
Sorafenib is active on lung metastases from synovial sarcoma. Ann Oncol (2009) 0.86
The follow-up of adult soft-tissue sarcomas. Semin Oncol (2003) 0.85
Management of soft tissue sarcomas of the extremity in adults. J Surg Oncol (1996) 0.85
Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg (2011) 0.84
Adjuvant radiotherapy in the management of soft tissue sarcoma involving the distal extremities. Am J Clin Oncol (2006) 0.83
Surgical treatment of metastatic disease to the lung. Semin Oncol (2008) 0.83
Tailoring tyrosine kinase inhibitors to fit the lung cancer genome. Transl Oncol (2011) 0.83
Clinicopathologic considerations: how can we fine tune our approach to sarcoma? Semin Oncol (2011) 0.82
The benefit of pulmonary metastectomy for bone and soft tissue sarcomas. Int Surg (2001) 0.81
Efficacy of pulmonary metastasectomy for recurrent soft tissue sarcoma. J Surg Oncol (1991) 0.81
Trabectedin for the management of soft-tissue sarcoma. Expert Rev Anticancer Ther (2009) 0.80
Update on the management of connective tissue malignancies. Semin Oncol (2004) 0.80
Limb-sparing surgery for extremity sarcoma. Cancer Invest (1994) 0.78
The role of adjuvant chemotherapy in the treatment of adult soft tissue sarcomas. Crit Rev Oncol Hematol (1998) 0.76
Surgical treatment of metastatic pulmonary soft-tissue sarcoma. Oncology (Williston Park) (2000) 0.76
Integrating novel therapies into the treatment of sarcoma: a multidisciplinary approach--introduction. Semin Oncol (2011) 0.76
Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas. Ann Surg Oncol (1998) 0.75
Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. J Cancer (2013) 1.31
Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Des Devel Ther (2013) 1.14
First report of a novel liquid nitrogen adjustable flow spray cryotherapy (SCT) device in the bronchoscopic treatment of disease of the central tracheo-bronchial airways. J Thorac Dis (2013) 0.93
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis. Onco Targets Ther (2013) 0.83
New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam. Int J Pharm (2013) 0.79
Massive hemoptysis in a patient with sarcoidosis. J Bronchology Interv Pulmonol (2009) 0.75